Sarah Gheuens, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 2,642 shares at $32.57 ($86K) on 2024-03-05, disclosed to the SEC on 2024-03-05.
Scheduled sale ($86k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.57 | 1,293 | $42K | 48.9% |
| 2 | $32.57 | 1,349 | $44K | 51.1% |
| Total | $32.57 avg | 2,642 | $86K | 100% |
| Filing → |
| AGIO | SELL | 2026-04-06 | $102K | — | Filing → |
| AGIO | SELL | 2026-03-03 | $83K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |